Emerald Mutual Fund Advisers Trust’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ELOX Stock Details ELOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,636	Closed	-$657K	–	306
2019 Q3	$657K	Sell	3,636 -1,364	-27%	-$388K	0.03%	188
2019 Q2	$1.99M	Hold	5,000	–	–	0.08%	176
2019 Q1	$2.34M	Hold	5,000	–	–	0.09%	182
2018 Q4	$2.4M	Hold	5,000	–	–	0.11%	176
2018 Q3	$3.41M	Hold	5,000	–	–	0.12%	190
2018 Q2	$3.41M	Buy	+5,000	New	+$3.24M	0.12%	179

Other funds holding ELOX

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ELOX Position: Q4 2019 in Review

Emerald Mutual Fund Advisers Trust sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2019, closing a stake of 3,636 shares — an estimated $657K sold.

Emerald Mutual Fund Advisers Trust first reported a position in ELOX in Q2 2018 and held it in 6 quarters. The position peaked at $3.41M in Q2 2018. 46 funds tracked by Wall St. Rank hold ELOX as of Q4 2019.

Emerald Mutual Fund Advisers Trust reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 3,636 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $657K.
Emerald Mutual Fund Advisers Trust first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Emerald Mutual Fund Advisers Trust's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $3.41M in Q2 2018.
46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2019, filed 29 Jan 2020.